Lipofuscin Granule Bisretinoid Oxidation in the Human Retinal Pigment Epithelium forms Cytotoxic Carbonyls.
Aged
Aldehydes
/ metabolism
Cytoplasm
/ metabolism
Fluorescent Dyes
/ metabolism
Humans
Lipofuscin
/ metabolism
Macular Degeneration
/ metabolism
Middle Aged
Oxidation-Reduction
Retinal Pigment Epithelium
/ metabolism
Retinoids
/ metabolism
Spectrometry, Fluorescence
/ methods
Spectrometry, Mass, Secondary Ion
/ methods
age-related macular degeneration
amphiphilicity
bisretinoid fluorophores
bisretinoid oxidation products
cytotoxic carbonyls
hydrophilicity
lipofuscin granules
retinal pigment epithelium
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Dec 2021
25 Dec 2021
Historique:
received:
19
11
2021
revised:
16
12
2021
accepted:
22
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
3
2
2022
Statut:
epublish
Résumé
Age-related macular degeneration (AMD) is the primary cause of central blindness among the elderly. AMD is associated with progressive accumulation of lipofuscin granules in retinal pigment epithelium (RPE) cells. Lipofuscin contains bisretinoid fluorophores, which are photosensitizers and are phototoxic to RPE and neuroretinal cells. In the presence of oxygen, bisretinoids are also oxidized, forming various products, consisting primarily of aldehydes and ketones, which are also potentially cytotoxic. In a prior study, we identified that in AMD, bisretinoid oxidation products are increased in RPE lipofuscin granules. The purpose of the present study was to determine if these products were toxic to cellular structures. The physicochemical characteristics of bisretinoid oxidation products in lipofuscin, which were obtained from healthy donor eyes, were studied. Raman spectroscopy and time-of-flight secondary ion mass spectrometry (ToF-SIMS) analysis identified the presence of free-state aldehydes and ketones within the lipofuscin granules. Together, fluorescence spectroscopy, high-performance liquid chromatography, and mass spectrometry revealed that bisretinoid oxidation products have both hydrophilic and amphiphilic properties, allowing their diffusion through lipofuscin granule membrane into the RPE cell cytoplasm. These products contain cytotoxic carbonyls, which can modify cellular proteins and lipids. Therefore, bisretinoid oxidation products are a likely aggravating factor in the pathogenesis of AMD.
Identifiants
pubmed: 35008647
pii: ijms23010222
doi: 10.3390/ijms23010222
pmc: PMC8745408
pii:
doi:
Substances chimiques
Aldehydes
0
Fluorescent Dyes
0
Lipofuscin
0
Retinoids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : The Ministry of Science and Higher Education of Russia
ID : 075-15-2020-795 (local identifier 13.1902.21.0027)
Références
Vision Res. 2010 Mar 31;50(7):729-36
pubmed: 19800359
Oxid Med Cell Longev. 2020 Feb 10;2020:7901270
pubmed: 32104539
Invest Ophthalmol Vis Sci. 1984 Feb;25(2):195-200
pubmed: 6698741
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14609-13
pubmed: 9843937
Exp Eye Res. 2005 May;80(5):595-606
pubmed: 15862166
J Photochem Photobiol B. 1993 Aug;19(3):201-4
pubmed: 8229462
Free Radic Biol Med. 1996;21(6):871-88
pubmed: 8902532
Dokl Biochem Biophys. 2005 Nov-Dec;405:458-60
pubmed: 16480152
Nanomaterials (Basel). 2017 Nov 04;7(11):
pubmed: 29113056
Redox Biol. 2014 Jan 09;2:411-29
pubmed: 24624331
Trans Ophthalmol Soc U K. 1983;103 ( Pt 4):416-21
pubmed: 6589859
J Mass Spectrom. 2011 Jan;46(1):90-5
pubmed: 21182214
Arch Gerontol Geriatr. 2002 May-Jun;34(3):359-70
pubmed: 14764336
Methods Enzymol. 1978;52:302-10
pubmed: 672633
Ann N Y Acad Sci. 2007 Nov;1119:97-111
pubmed: 18056959
Am J Ophthalmol. 2004 Mar;137(3):504-10
pubmed: 15013875
Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1433-43
pubmed: 2387677
Antioxidants (Basel). 2020 Nov 20;9(11):
pubmed: 33233726
Nat Biotechnol. 1999 Oct;17(10):1006-10
pubmed: 10504703
J Biol Chem. 2003 May 16;278(20):18207-13
pubmed: 12646558
Dokl Biochem Biophys. 2009 Mar-Apr;425:98-101
pubmed: 19496332
Photochem Photobiol. 2006 Sep-Oct;82(5):1251-7
pubmed: 16813456
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1981-9
pubmed: 10845625
Photochem Photobiol. 2004 Feb;79(2):127-36
pubmed: 15068025
Dokl Biochem Biophys. 2006 Jul-Aug;409:223-5
pubmed: 16986436
Angew Chem Int Ed Engl. 2010 Sep 10;49(38):6773-7
pubmed: 20680954
Contrib Nephrol. 2001;(131):1-9
pubmed: 11125554
Angew Chem Int Ed Engl. 2002 Mar 1;41(5):814-7
pubmed: 12491345
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Aging Dis. 2013 Oct 01;4(5):276-94
pubmed: 24124633
Annu Rev Biomed Eng. 2015;17:415-45
pubmed: 26514285
Physiol Rev. 2014 Jul;94(3):909-50
pubmed: 24987008
J Mass Spectrom. 2010 Oct;45(10):1139-47
pubmed: 20860013
Exp Eye Res. 2017 Feb;155:121-127
pubmed: 28219732
Exp Eye Res. 2004 Oct;79(4):537-42
pubmed: 15381037
Prog Retin Eye Res. 2012 Mar;31(2):121-35
pubmed: 22209824
Arch Biochem Biophys. 2003 Nov 1;419(1):31-40
pubmed: 14568006
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):737-43
pubmed: 10067978
Toxicol Pathol. 2002 Nov-Dec;30(6):620-50
pubmed: 12512863
Anal Bioanal Chem. 2015 Feb;407(4):1075-88
pubmed: 25471291
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7275-80
pubmed: 20368460
Antioxidants (Basel). 2020 Nov 20;9(11):
pubmed: 33233546
Eye (Lond). 2018 Sep;32(9):1440-1448
pubmed: 29786089
Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
pubmed: 11033038
J Biol Chem. 2005 Dec 2;280(48):39732-9
pubmed: 16186115
Optom Vis Sci. 2014 Aug;91(8):832-48
pubmed: 24879089
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD41-AMD47
pubmed: 30025108
Photochem Photobiol. 2005 Nov-Dec;81(6):1305-30
pubmed: 16120006
Arch Ophthalmol. 2004 May;122(5):750-7
pubmed: 15136324
Adv Exp Med Biol. 2008;613:393-8
pubmed: 18188969
Opt Express. 2006 Apr 17;14(8):3622-30
pubmed: 19516509
Ophthalmologe. 2000 Oct;97(10):682-7
pubmed: 11105544
Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):183000
pubmed: 31152688
J Clin Invest. 2014 Apr;124(4):1430-8
pubmed: 24691477
PLoS One. 2012;7(7):e41309
pubmed: 22829938
Methods Enzymol. 1990;186:407-21
pubmed: 2233308
Adv Exp Med Biol. 2018;1074:395-401
pubmed: 29721969
Photochem Photobiol Sci. 2020 Jul 1;19(7):920-930
pubmed: 32441276
AIMS Mol Sci. 2016;3(2):196-221
pubmed: 27239555
Eye (Lond). 1995;9 ( Pt 6):763-71
pubmed: 8849547